Skip to main content
. 2021 May 7;54(3):964–974. doi: 10.1002/jmri.27662

TABLE 1.

Clinical Characteristics and Pre‐Treatment Pulmonary Function of the Study Population

Patient Sex Age (years) FEV1% pred FVC% pred TLC% pred RV% pred DLCO% pred
01 F 55 29 74 124 206 42
02 F 67 33 74 113 155 52
03 F 71 75 98 84 64 51
04 M 64 66 97 88 72 39
05 F 58 29 66 104 150 36
06 M 66 61 77 92 121 75
07 F 64 61 91 96 98 76
08 M 74 64 96 101 104 34
09 M 69 43 76 96 134 71
10 F 61 51 73 95 123 64
11 M 59 68 94 95 98 66
12 F 66 48 60 96 143 104
13 F 66 42 89 125 173 32
14 F 67 57 90 129 167 67
15 M 67 38 67 NA NA 54
16 M 58 45 97 112 144 56
17 M 61 70 90 99 121 64
Mean 64.3 52 83 103 127 58
SD 4.9 15 13 12 29 19

All pulmonary function tests expressed as percent predicted (%).

DLCO = diffusion capacity of the lung for carbon monoxide; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; RV = residual volume; TLC = total lung capacity.